Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026)

bioAffinity Technologies has reported Non-Current Assets over the past 6 years, most recently at $3.6 million for Q1 2026.

  • Quarterly Non-Current Assets fell 2.16% to $3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.0 million through Mar 2026, down 15.93% year-over-year, with the annual reading at $3.4 million for FY2025, 11.08% down from the prior year.
  • Non-Current Assets was $3.6 million for Q1 2026 at bioAffinity Technologies, up from $3.4 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $4.2 million in Q4 2023 and troughed at $7781.0 in Q3 2022.
  • The 5-year median for Non-Current Assets is $3.6 million (2026), against an average of $2.8 million.
  • Year-over-year, Non-Current Assets skyrocketed 53611.03% in 2023 and then decreased 26.73% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $220438.0 in 2022, then skyrocketed by 1827.44% to $4.2 million in 2023, then decreased by 10.13% to $3.8 million in 2024, then dropped by 11.08% to $3.4 million in 2025, then increased by 6.13% to $3.6 million in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Non-Current Assets are $3.6 million (Q1 2026), $3.4 million (Q4 2025), and $2.9 million (Q3 2025).